Home Medical Devices Smart Pills Market Size, Share, Players & Trends by 2034

Smart Pills Market Size & Outlook, 2026-2034

Smart Pills Market Size, Share & Trends Analysis Report By Indication (Celiac Disease, Small Bowel Diseases, Colon Cancer, Others), By Application (Capsule Endoscopy, Drug Delivery, Vital Sign Monitoring), By End User (Hospitals and Clinics, Diagnostic Centers) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Report Code: SRMD57660DR
Last Updated : Oct, 2025
Pages : 110
Author : Debashree Bora
Format : PDF, Excel

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Smart Pills Market Introduction
    2. By Indication
      1. Introduction
        1. Indication By Value
      2. Celiac Disease
        1. By Value
      3. Small Bowel Diseases
        1. By Value
      4. Colon Cancer
        1. By Value
      5. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Capsule Endoscopy
        1. By Value
      3. Drug Delivery
        1. By Value
      4. Vital Sign Monitoring
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Diagnostic Centers
        1. By Value
    1. Introduction
    2. By Indication
      1. Introduction
        1. Indication By Value
      2. Celiac Disease
        1. By Value
      3. Small Bowel Diseases
        1. By Value
      4. Colon Cancer
        1. By Value
      5. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Capsule Endoscopy
        1. By Value
      3. Drug Delivery
        1. By Value
      4. Vital Sign Monitoring
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Diagnostic Centers
        1. By Value
    5. U.S.
      1. By Indication
        1. Introduction
          1. Indication By Value
        2. Celiac Disease
          1. By Value
        3. Small Bowel Diseases
          1. By Value
        4. Colon Cancer
          1. By Value
        5. Others
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Capsule Endoscopy
          1. By Value
        3. Drug Delivery
          1. By Value
        4. Vital Sign Monitoring
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Diagnostic Centers
          1. By Value
    6. Canada
    1. Introduction
    2. By Indication
      1. Introduction
        1. Indication By Value
      2. Celiac Disease
        1. By Value
      3. Small Bowel Diseases
        1. By Value
      4. Colon Cancer
        1. By Value
      5. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Capsule Endoscopy
        1. By Value
      3. Drug Delivery
        1. By Value
      4. Vital Sign Monitoring
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Diagnostic Centers
        1. By Value
    5. U.K.
      1. By Indication
        1. Introduction
          1. Indication By Value
        2. Celiac Disease
          1. By Value
        3. Small Bowel Diseases
          1. By Value
        4. Colon Cancer
          1. By Value
        5. Others
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Capsule Endoscopy
          1. By Value
        3. Drug Delivery
          1. By Value
        4. Vital Sign Monitoring
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Diagnostic Centers
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Indication
      1. Introduction
        1. Indication By Value
      2. Celiac Disease
        1. By Value
      3. Small Bowel Diseases
        1. By Value
      4. Colon Cancer
        1. By Value
      5. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Capsule Endoscopy
        1. By Value
      3. Drug Delivery
        1. By Value
      4. Vital Sign Monitoring
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Diagnostic Centers
        1. By Value
    5. China
      1. By Indication
        1. Introduction
          1. Indication By Value
        2. Celiac Disease
          1. By Value
        3. Small Bowel Diseases
          1. By Value
        4. Colon Cancer
          1. By Value
        5. Others
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Capsule Endoscopy
          1. By Value
        3. Drug Delivery
          1. By Value
        4. Vital Sign Monitoring
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Diagnostic Centers
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Indication
      1. Introduction
        1. Indication By Value
      2. Celiac Disease
        1. By Value
      3. Small Bowel Diseases
        1. By Value
      4. Colon Cancer
        1. By Value
      5. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Capsule Endoscopy
        1. By Value
      3. Drug Delivery
        1. By Value
      4. Vital Sign Monitoring
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Diagnostic Centers
        1. By Value
    5. UAE
      1. By Indication
        1. Introduction
          1. Indication By Value
        2. Celiac Disease
          1. By Value
        3. Small Bowel Diseases
          1. By Value
        4. Colon Cancer
          1. By Value
        5. Others
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Capsule Endoscopy
          1. By Value
        3. Drug Delivery
          1. By Value
        4. Vital Sign Monitoring
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Diagnostic Centers
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Indication
      1. Introduction
        1. Indication By Value
      2. Celiac Disease
        1. By Value
      3. Small Bowel Diseases
        1. By Value
      4. Colon Cancer
        1. By Value
      5. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Capsule Endoscopy
        1. By Value
      3. Drug Delivery
        1. By Value
      4. Vital Sign Monitoring
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Diagnostic Centers
        1. By Value
    5. Brazil
      1. By Indication
        1. Introduction
          1. Indication By Value
        2. Celiac Disease
          1. By Value
        3. Small Bowel Diseases
          1. By Value
        4. Colon Cancer
          1. By Value
        5. Others
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Capsule Endoscopy
          1. By Value
        3. Drug Delivery
          1. By Value
        4. Vital Sign Monitoring
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Diagnostic Centers
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Smart Pills Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Medtronic
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Otsuko America Pharmaceutical, Inc.
    3. Olympus America
    4. CapsoVision, Inc
    5. Pentax Medical
    6. BDD Ltd
    7. JINSHAN Science & Technology 
    8. etectRx
    9. INTROMEDIC 
    10. BodyCAP
    11. Check-Cap Ltd.
    12. Abbott
    13. GE HealthCare
    14. Bio-Images & Medimetrics
    15. RF Co., Ltd.
    16. Tenovi
    17. Koninklijke Philips N.V.,
    18. Proteus Digital Health, Inc.
    19. JINSHAN Science & Technology
    20. Novartis AG
    21. Others
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Available for purchase with detailed segment data, forecasts, and regional insights.

Get This Report

Download Free Sample

Note: Please ensure you provide an active email address as we will be sending sample details via email.
The button will be active once the above form is filled

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on :

Address:
Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
DMCA.com Protection Status
Secure Payments:
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.